Mobile Stroke Units: Field Imaging and Triage for Acute Stroke Emergencies

  • Anne W. Alexandrov
  • Nitin Goyal
  • Abhi Pandhi
  • Sarah McCormick
  • Andrei V. Alexandrov
  • Adam ArthurEmail author


Stroke is a pandemic affecting people of all populations and ages. In the past few decades, the global stroke burden has increased significantly worldwide especially between the years 1990 and 2013 (Feigin VL, Norrving B, George MG et al, Nat Rev Neurol 12(9):501–512, 2016). Currently available acute ischemic stroke (AIS) treatments are intravenous recombinant tissue plasminogen activator (rtPA) and, in the case of emergent large vessel occlusion (ELVO), mechanical thrombectomy (MT) (The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, N Engl J Med 333(24):1581–1587, 1995; Berkhemer OA, Fransen PS, Beumer D et al, N Engl J Med 372(1):11–20, 2015; Goyal M, Demchuk AM, Menon BK et al, N Engl J Med 372(11):1019–1030, 2015; Campbell BC, Mitchell PJ, Kleinig TJ et al, N Engl J Med 372(11):1009–1018., 2015; Saver JL, Goyal M, Bonafe A et al, N Engl J Med 372(24):2285–2295, 2015; Jovin TG, Chamorro A, Cobo E et al, N Engl J Med 372(24):2296–2306, 2015); however, few patients receive these time-dependent treatments. The concept of taking stroke care to the patient by deployment of mobile stroke units (MSU) is gaining momentum. In this chapter, we explore the use of AIS treatments, management of contributors to treatment delays, and the history and utility of MSUs to support acute stroke treatment.


Mobile stroke units Field imaging for stroke Stroke emergencies Triage for stroke Stroke triage and field imaging Acute ischemic stroke treatment 


  1. 1.
    Feigin VL, Norrving B, George MG, et al. Prevention of stroke: a strategic global imperative. Nat Rev Neurol. 2016;12(9):501–12.Google Scholar
  2. 2.
    The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581–7.Google Scholar
  3. 3.
    Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372(1):11–20.Google Scholar
  4. 4.
    Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372(11):1019–30.Google Scholar
  5. 5.
    Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372(11):1009–18. Scholar
  6. 6.
    Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372(24):2285–95.Google Scholar
  7. 7.
    Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372(24):2296–306.Google Scholar
  8. 8.
    Heart and Stroke. Accessed 15 Jan 2017.
  9. 9.
    Millan M, Dorado L, Davalos A. Fibrinolytic therapy in acute stroke. Curr Cardiol Rev. 2010;6(3):218–26.PubMedCentralPubMedGoogle Scholar
  10. 10.
    Robinson T, Zaheer Z, Mistr AK. Thrombolysis in acute ischemic stroke. Ther Adv Chronic Dis. 2011;2(2):119–31.PubMedCentralPubMedGoogle Scholar
  11. 11.
    Adeoye O, Hornung R, Khatri P, et al. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke. 2011;42(7):1952–5.PubMedCentralPubMedGoogle Scholar
  12. 12.
    Donnan GA, Baron JC, Ma H, Davis SM. Penumbral selection of patients for trials of acute stroke therapy. Lancet Neurol. 2009;8(3):261–9.Google Scholar
  13. 13.
    Meretoja A, Weir L, Ugalde M, et al. Helsinki model cut stroke thrombolysis delays to 25 minutes in Melbourne in only 4 months. Neurology. 2013;81(12):1071–6.Google Scholar
  14. 14.
    Gladstone DJ, Rodan LH, Sahlas DJ, et al. A citywide prehospital protocol increases access to stroke thrombolysis in Toronto. Stroke. 2009;40(12):3841–4.Google Scholar
  15. 15.
    O’Brien W, Crimmins D, Donaldson W, et al. FASTER (Face, Arm, Speech, Time, Emergency Response): experience of Central Coast Stroke Services implementation of a pre-hospital notification system for expedient management of acute stroke. J Clin Neurosci. 2012;19(2):241–5.Google Scholar
  16. 16.
    Quinn TJ, Dawson J, Walters MR, Lees KR. Functional outcome measures in contemporary stroke trials. Int J Stroke. 2009;4(3):200–5.Google Scholar
  17. 17.
    Haass A, Walter S, Ragoschke-Schumm A, et al. “Time is brain”. Optimizing prehospital stroke management. Nervenarzt. 2014;85(2):189–94.Google Scholar
  18. 18.
    Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375(9727):1695–703.Google Scholar
  19. 19.
    Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363(9411):768–74.Google Scholar
  20. 20.
    Fagan SC, Morgenstern LB, Petitta A, et al. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology. 1998;50(4):883–90.Google Scholar
  21. 21.
    Marler JR, Tilley BC, Lu M, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology. 2000;55(11):1649–55.Google Scholar
  22. 22.
    Lansberg MG, Schrooten M, Bluhmki E, Thijs VN, Saver JL. Treatment time-specific number needed to treat estimates for tissue plasminogen activator therapy in acute stroke based on shifts over the entire range of the modified Rankin Scale. Stroke. 2009;40(6):2079–84.PubMedCentralPubMedGoogle Scholar
  23. 23.
    Khatri P, Abruzzo T, Yeatts SD, et al. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology. 2009;73(13):1066–72.PubMedCentralPubMedGoogle Scholar
  24. 24.
    Saver JL, Goyal M, van der Lugt A, et al. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA. 2016;316(12):1279–88.Google Scholar
  25. 25.
    Saver JL, Fonarow GC, Smith EE, Reeves MJ, Grau-Sepulveda MV, Pan W, Olson DM, Hernandez AF, Peterson ED, Schwamm LH. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA. 2013;309(23):2480–8.Google Scholar
  26. 26.
    Cheng NT, Kim AS. Intravenous thrombolysis for acute ischemic stroke within 3 hours versus between 3 and 4.5 hours of symptom onset. Neurohospitalist. 2015;5(3):101–9.PubMedCentralPubMedGoogle Scholar
  27. 27.
    Fonarow GC, Smith EE, Saver JL, et al. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation. 2011;123(7):750–8.Google Scholar
  28. 28.
    Herlitz J, Wireklintsundström B, Bång A, et al. Early identification and delay to treatment in myocardial infarction and stroke: differences and similarities. Scand J Trauma Resusc Emerg Med. 2010;18:48.PubMedCentralPubMedGoogle Scholar
  29. 29.
    Dombrowski SU, Mackintosh JE, Sniehotta FF, et al. The impact of the UK ‘Act FAST’ stroke awareness campaign: content analysis of patients, witness and primary care clinicians’ perceptions. BMC Public Health. 2013;13:915.PubMedCentralPubMedGoogle Scholar
  30. 30.
    Ragoschke-Schumm A, Walter S, Haass A, et al. Translation of the ‘time is brain’ concept into clinical practice: focus on prehospital stroke management. Int J Stroke. 2014;9(3):333–40.PubMedCentralPubMedGoogle Scholar
  31. 31.
    Wojner-Alexandrov AW, Alexandrov AV, Rodriguez D, Persse D, Grotta JC. Houston paramedic and emergency stroke treatment and outcomes study (HoPSTO). Stroke. 2005;36(7):1512–8.Google Scholar
  32. 32.
    Walter S, Kostopoulos P, Haass A, et al. Point-of-care laboratory halves door-to-therapy-decision time in acute stroke. Ann Neurol. 2011;69:581–6.Google Scholar
  33. 33.
    Middleton S, Grimley R, Alexandrov AW. Triage, treatment and transfer: evidence-based clinical practice recommendations and models of nursing care for the first 72 hours of admission to hospital for acute stroke. Stroke. 2015;46(2):e18–25.Google Scholar
  34. 34.
    Ebinger M, Lindenlaub S, Kunz A, et al. Prehospital thrombolysis: a manual from Berlin. J Vis Exp. 2013;81:e50534.Google Scholar
  35. 35.
    Walter S, Kostpopoulos P, Haass A, et al. Bringing the hospital to the patient: first treatment of stroke patients at the emergency site. PLoS One. 2010;5(10):e13758.PubMedCentralPubMedGoogle Scholar
  36. 36.
    Ebinger M, Fiebach JB, Audebert HJ. Mobile computed tomography: prehospital diagnosis and treatment of stroke. Curr Opin Neurol. 2015;28(1):4–9.PubMedGoogle Scholar
  37. 37.
    Walter S, Kostopoulos P, Haass A, et al. Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: a randomised controlled trial. Lancet Neurol. 2012;11(5):397–404.PubMedGoogle Scholar
  38. 38.
    Wendt M, Ebinger M, Kunz A, et al. Improved prehospital triage of patients with stroke in a specialized stroke ambulance: results of the pre-hospital acute neurological therapy and optimization of medical care in stroke study. Stroke. 2015;46(3):740–5.PubMedGoogle Scholar
  39. 39.
    Ebinger M, Kunz A, Wendt M, et al. Effects of golden hour thrombolysis: a Prehospital Acute Neurological Treatment and Optimization of Medical Care in Stroke (PHANTOM-S) substudy. JAMA Neurol. 2015;72(1):25–30.PubMedGoogle Scholar
  40. 40.
    Ebinger M, Rozanski M, Waldschmidt C, et al. PHANTOM-S: the prehospital acute neurological therapy and optimization of medical care in stroke patients – study. Int J Stroke. 2012;7(4):348–53.Google Scholar
  41. 41.
    Weber JE, Ebinger M, Rozanski M, et al. Prehospital thrombolysis in acute stroke: results of the PHANTOM-S pilot study. Neurology. 2013;80(2):163–8.Google Scholar
  42. 42.
    Parker SA, Bowry R, Wu TC, et al. Establishing the first mobile stroke unit in the United States. Stroke. 2015;46(5):1384–91.Google Scholar
  43. 43.
    Bowry R, Parker S, Rajan SS, et al. Benefits of stroke treatment using a mobile stroke unit compared with standard management: the BEST-MSU study run-in phase. Stroke. 2015;46(12):3370–4.Google Scholar
  44. 44.
    John S, Stock S, Cerejo R, et al. Brain imaging using mobile CT: current status and future prospects. J Neuroimaging. 2016;26(1):5–15.Google Scholar
  45. 45.
    Itrat A, Taqui A, Cerejo R, et al. Telemedicine in prehospital stroke evaluation and thrombolysis: taking stroke treatment to the doorstep. JAMA Neurol. 2016;73(2):162–8.Google Scholar
  46. 46.
    Rasmussen PA. Stroke management and the impact of mobile stroke treatment units. Cleve Clin J Med. 2015;82(12 Suppl 2):S17–21.Google Scholar
  47. 47.
    Cerejo R, John S, Buletko AB, et al. A mobile stroke treatment unit for field triage of patients for Intraarterial revascularization therapy. J Neuroimaging. 2015;25(6):940–5.Google Scholar
  48. 48.
    National Association of Emergency Medical Technicians (NAEMT). Accessed 15 Dec 2016.
  49. 49.
    Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Peripheral Vascular Disease, Council on Clinical Cardiology, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870–947.PubMedCentralPubMedGoogle Scholar
  50. 50.
    Wu T-Z, Parker SA, Jagolino A, Yamal JM, Bowry R, Thomas A, et al. Telemedicine can replace the neurologist on a mobile stroke unit. Stroke. 2017;48:493. Scholar
  51. 51.
    APRN Consensus Work Group & the National Council of State Boards of Nursing APRN Advisory Committee. Consensus Model of APRN Regulation: Licensure, Accreditation, Certification & Education. 2008. http:/// Accessed 15 Dec 2016.
  52. 52.
    American Nurse Credentialing Center. ANCC Certification Center. 2013. Accessed 16 Dec 2016.
  53. 53.
    U.S. Drug Enforcement Agency. Mid-Level Providers Authorization by State. 2013. Accessed 15 Dec 2016.
  54. 54.
    National Council of State Boards of Nursing I. NCSBN’s APRN Campaign for Consensus: State Progress toward Uniformity. 2013. Accessed 15 Dec 2016.
  55. 55.
    Health Outcomes Institute, NET SMART. Accessed 15 Dec 2016.
  56. 56.
    Association of Neurovascular Clinicians. Accessed 15 Dec 2016.
  57. 57.
    American Registry of Radiologic Technologists. Accessed 15 Dec 2016.
  58. 58.
    Gutiérrez JM, Emery RJ, Parker SA, et al. Radiation monitoring results from the first year of operation of a unique ambulance-based computed tomography unit for the improved diagnosis and treatment of stroke patients. Health Phys. 2016;110(5 Suppl 2):S73–80.Google Scholar
  59. 59.
    Pourshaikhian M, Gorji HA, Aryankhesal A, Khorasani-Zavareh D, Barati A. A systematic literature review: workplace violence against emergency medical services personnel. Arch Trauma Resusc. 2016;5(1):e28734.Google Scholar
  60. 60.
    Audebert H, Fassbender K, Hussein S, Ebinger M, Turc G, Davis S, Alexandrov AW, Grotta JC, on Behalf of the PRESTO Group. The PRE-hospital Stroke Treatment Organization (PRESTO). Int J Stroke. 2017;12(9):932–40.Google Scholar
  61. 61.
    Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(7):2032–60.Google Scholar
  62. 62.
    Frontera JA, Lewin JJ, Rabinstein AA, Aisiku IP, Alexandrov AW, Cook AM, del Zoppo GJ, Kumar M, Peerschke EIB, Stiefel MF, Teitelbaum JS, Wartenberg KE, Zerfoss CL. Guideline for reversal of antithrombotics in intracranial hemorrhage: executive summary, a statement for healthcare professionals from the Neurocritical care society and Society of Critical Care Medicine. Crit Care Med. 2016;44:2251–7.Google Scholar
  63. 63.
    Gomes JA, Ahrens CL, Hussain MS, et al. Prehospital reversal of warfarin-related coagulopathy in intracerebral hemorrhage in a mobile stroke treatment unit. Stroke. 2015;46(5):e118–20.Google Scholar
  64. 64.
    Bederson JB, Connolly ES, Batjer HH, Dacey RG, Dion JE, Diringer MN, Duldner JE, Harbaugh RE, Patel AB, Rosenwasser RH. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare providers from a special writing group of the stroke council. Am Heart Assoc Stroke. 2009;40:994–1025.Google Scholar
  65. 65.
    Rajan SS, Baraniuk S, Parker S, et al. Implementing a mobile stroke unit program in the United States: why, how, and how much? JAMA Neurol. 2015;72(2):229–34.Google Scholar
  66. 66.
    Chernyshev OY, Martin-Schild S, Albright KC, et al. Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia. Neurology. 2010;74(17):1340–5.PubMedCentralPubMedGoogle Scholar
  67. 67.
    Tsivgoulis G, Zand R, Katsanos AH, et al. Safety of intravenous thrombolysis in stroke mimics: prospective 5-year study and comprehensive meta-analysis. Stroke. 2015;46(5):1281–7.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Anne W. Alexandrov
    • 1
    • 2
  • Nitin Goyal
    • 1
  • Abhi Pandhi
    • 1
  • Sarah McCormick
    • 1
  • Andrei V. Alexandrov
    • 1
  • Adam Arthur
    • 1
    • 3
    Email author
  1. 1.Department of Neurology, College of MedicineUniversity of Tennessee Health Science CenterMemphisUSA
  2. 2.College of NursingUniversity of Tennessee Health Science CenterMemphisUSA
  3. 3.Semmes-Murphy Neurologic and Spine ClinicMemphisUSA

Personalised recommendations